|
ANG Lifesciences India Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
43.09 Cr.
|
P/BV
|
0.89
|
Book Value (Rs.)
|
37.25
|
|
52 Week High/Low (Rs.)
|
50/18
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -8.43 | -9.42 | -7.65 | 0.36 | 39.39 |
| Diluted EPS (Rs.) | -8.43 | -9.42 | -7.65 | 0.36 | 39.09 |
| Cash EPS (Rs.) | -3.64 | -4.33 | -1.36 | 6.96 | 44.56 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 40.50 | 48.99 | 58.41 | 66.02 | 80.81 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 40.50 | 48.99 | 58.41 | 66.02 | 80.81 |
| Revenue From Operations / Share (Rs.) | 71.14 | 71.10 | 111.89 | 168.39 | 341.77 |
| PBDIT / Share (Rs.) | 0.95 | -0.18 | 7.92 | 18.27 | 65.87 |
| PBIT / Share (Rs.) | -3.89 | -5.37 | 1.51 | 11.11 | 60.20 |
| PBT / Share (Rs.) | -9.96 | -12.03 | -8.20 | 2.01 | 51.61 |
| Net Profit / Share (Rs.) | -8.49 | -9.51 | -7.77 | -0.20 | 38.89 |
| NP After MI And SOA / Share (Rs.) | -8.49 | -9.51 | -7.77 | -0.20 | 38.89 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 1.34 | -0.26 | 7.07 | 10.84 | 19.27 |
| PBIT Margin (%) | -5.46 | -7.54 | 1.34 | 6.59 | 17.61 |
| PBT Margin (%) | -14.00 | -16.91 | -7.33 | 1.19 | 15.10 |
| Net Profit Margin (%) | -11.93 | -13.36 | -6.94 | -0.11 | 11.37 |
| NP After MI And SOA Margin (%) | -11.93 | -13.36 | -6.94 | -0.11 | 11.37 |
| Return on Networth / Equity (%) | -20.95 | -19.40 | -13.29 | -0.30 | 48.12 |
| Return on Capital Employeed (%) | -8.47 | -8.13 | 2.01 | 12.35 | 50.02 |
| Return On Assets (%) | -5.30 | -5.40 | -4.18 | -0.09 | 13.85 |
| Long Term Debt / Equity (X) | 0.08 | 0.29 | 0.18 | 0.23 | 0.25 |
| Total Debt / Equity (X) | 1.47 | 1.26 | 0.90 | 0.81 | 0.91 |
| Asset Turnover Ratio (%) | 0.42 | 0.39 | 0.55 | 0.77 | 0.00 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.00 | 1.15 | 1.24 | 1.15 | 1.16 |
| Quick Ratio (X) | 0.69 | 0.77 | 0.90 | 0.85 | 0.93 |
| Inventory Turnover Ratio (X) | 1.85 | 1.82 | 2.14 | 3.65 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 2.57 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 2.24 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 97.43 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 97.76 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.15 | -0.02 | 0.94 | 2.01 | 7.67 |
| Interest Coverage Ratio (Post Tax) (%) | -0.39 | -0.42 | 0.23 | 0.97 | 5.53 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 97.79 | 106.47 | 122.38 | 163.11 | 313.54 |
| EV / Net Operating Revenue (X) | 1.05 | 1.15 | 0.83 | 0.74 | 0.88 |
| EV / EBITDA (X) | 78.18 | -429.30 | 11.83 | 6.84 | 4.59 |
| MarketCap / Net Operating Revenue (X) | 0.25 | 0.31 | 0.40 | 0.45 | 0.68 |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 97.42 |
| Price / BV (X) | 0.45 | 0.46 | 0.77 | 1.15 | 2.90 |
| Price / Net Operating Revenue (X) | 0.25 | 0.31 | 0.40 | 0.45 | 0.68 |
| EarningsYield | -0.46 | -0.41 | -0.17 | 0.00 | 0.16 |
